HEALTHSTREAM INC
Pacira BioSciences (PCRX) surged 44% to $36.46 after Vitaris agreed to acquire it for $1.65B. Veradermics (MANE) rose 14% to $136.72, while HealthStream (HSTM) gained 2% to $32.42. Concentra (CON) and Haemonetics (HAE) also hit 52-week highs on strong financials.
AbbVie (ABBV) hit a 52-week high of $274.94 after receiving FDA Breakthrough Therapy designations for Temab-A. HealthStream (HSTM) rose 2% to $32.42, reporting Q2 revenue growth of 12.5%. Organon (OGN) reached $13.79, with FDA review of MIUDELLA expected by Q2 2027. All three companies hit 52-week highs on October 6, 2026.
HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 18, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HealthStream, Inc. (the “Co
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning HSTM (HEALTHSTREAM INC). Coverage has skewed bullish: 2 bullish, 0 neutral, and 0 bearish.
Recent HSTM coverage spans corporate actions, earnings and market movers.
In the last 30 days, HSTM insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($4.3M). The most active reporter was FRIST ROBERT A JR, CEO and Chairman, with 1 filing.
Positive sentiment from earnings beat and raised guidance.
Strong earnings momentum may sustain the rally.
The grants represent modest compensation and are unlikely to move the stock materially.
The new large stake and registration rights could increase float pressure and affect short‑term price dynamics.
Large insider sell by the CEO may signal negative outlook, potentially pressuring the stock lower.
AlphAI scores every news story that mentions HSTM with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHSTREAM INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Pacira BioSciences (PCRX) surged 44% to $36.46 after Vitaris agreed to acquire it for $1.65B. Veradermics (MANE) rose 14% to $136.72, while HealthStream (HSTM) gained 2% to $32.42. Concentra (CON) and Haemonetics (HAE) also hit 52-week highs on strong financials.
2 min readAbbVie (ABBV) hit a 52-week high of $274.94 after receiving FDA Breakthrough Therapy designations for Temab-A. HealthStream (HSTM) rose 2% to $32.42, reporting Q2 revenue growth of 12.5%. Organon (OGN) reached $13.79, with FDA review of MIUDELLA expected by Q2 2027. All three companies hit 52-week highs on October 6, 2026.
2 min readHEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 18, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of HealthStream, Inc. (the “Co
1 min readWJRJJ Ventures disclosed a 9.6% stake in HealthStream, acquired through open-market buys and a deal at $29.50 per share. The investment includes a one-year standstill and registration rights. WJRJJ plans to hold shares for investment but may buy or sell more over time. Willis Johnson, managing member of WJRJJ, is involved in the investment.
2 min readFRIST ROBERT A JR (CEO and Chairman) sold 144,068 shares of HEALTHSTREAM INC (HSTM) at $29.50 ($4.25M total) on 2026-09-14.
1 min readHealthStream Inc. (NASDAQ: HSTM) raised $40M from WJRJJ Ventures LLC, owned by Copart Inc. (NASDAQ: CPRT) founder Willis Johnson. The deal involved 1.5M shares at $29.50 each, with proceeds earmarked for corporate purposes, including acquisitions. Johnson cited confidence in HealthStream's technology and strategy.
1 min readHEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 PRESS RELEASE For Immediate Release: Contact: Mollie Condra, Ph.D. Head, Investor Relations & Corporate Communications HealthStream, Inc. (615) 301-3237 mollie.condra@healthstream.com HealthStream Completes $40 Million Private Placement of Its Common Stock NASHVILLE,
1 min readHEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement On September 10, 2026, HealthStream, Inc., a Tennessee corporation (the “Company”), entered into the Second Amendment to Amended and Restated Revolving Credit Agreement (the “Second Amendment”), dated as of September 10, 2026,
1 min readHumana (HUM) and HealthStream (HSTM) partnered to expand caregiver training. Humana reported Q2 2026 adjusted EPS of $7.61, lowering FY GAAP EPS guidance to $6.52. HealthStream saw Q2 revenue rise 12.5% to $83.7M, with net income up 23.8%. Humana faces regulatory pressures, while HealthStream benefits from strong margins and a debt-free balance sheet.
2 min readHealthStream Inc. (HSTM) reported Q2 profit of $6.7 million, or 23 cents per share, on revenue of $83.7 million. The company expects full-year revenue of $327 million to $332 million, according to the report.
1 min read
